Component

Mouse ischemia-associated astrocyte glutamate handling

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

Where it participates (unsigned role)

  1. In the mouse ischemia study, carnosine treatment preserved astrocytic GLT-1 expression and decreased glutamate levels.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Mouse permanent MCAO; separate cultured-astrocyte results are not used here to assign culture species.
    limitations
    Preservation does not establish direct binding to GLT-1.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    Glutamate handling offered another downstream connection.
    primary_references
    Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20043985/ · DOI 10.1016/j.freeradbiomed.2009.12.021

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 468–474

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mouse permanent MCAO; separate cultured-astrocyte results are not used here to assign culture species. · source_derived_draft · unverified_draft

    ## carnosine-ischemia-transporter Glutamate handling offered another downstream connection. In the mouse ischemia study, carnosine treatment preserved astrocytic GLT-1 expression and decreased glutamate levels. Model: Mouse permanent MCAO; separate cultured-astrocyte results are not used here to assign culture species. Limitations: Preservation does not establish direct binding to GLT-1. Evidence access: Primary abstract Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20043985/ · DOI 10.1016/j.freeradbiomed.2009.12.021
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards